Biotech development company
Neovacs has raised €8.0M across 2 funding rounds from 1 investor, most recently a round in Aug 2021. Based in France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-08-19 | Other | €2.0M | European High Growth Opportunities Securitization Fund | View deal → |
| 2017-07-07 | Other | €6.0M | — | View deal → |
